Low molecular weight dextran in systemic sclerosis and Raynaud's phenomenon.
D000328:Adult; D000368:Aged; D001775:Blood Circulation / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D002986:Clinical Trials as Topic; D003911:Dextrans / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D004311:Double-Blind Method; D005385:Fingers; D005947:Glucose / Q000008:administration & dosage; D006801:Humans; D007263:Infusions, Parenteral; D008875:Middle Aged; D008970:Molecular Weight; D011928:Raynaud Disease / Q000188:drug therapy*; D012595:Scleroderma, Systemic / Q000188:drug therapy*
D003911:Dextrans; D005947:Glucose